Abbott Wins FDA Approval for Updated Heart Failure Monitoring Device

Abbott wins FDA approval for updated heart failure monitoring device

The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.

Abbott’s CardioMEMS Hero PA Pressure Reader Approved by FDA for Remote HF Monitoring

March 2, 2026—Abbott announced FDA approval of the CardioMEMS Hero device, its next-generation pulmonary artery (PA) pressure reader to support the care of patients with heart failure (HF). Abbott will soon begin commercial release of the Hero reader in the United States, advised the press release. According to the company, the Hero reader is a new component of its CardioMEMS HF system and is designed to work with the CardioMEMS PA sensor. As ou…

Abbott’s next-generation PA pressure reader gains US FDA approval

CardioMEMS sensor Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s CardioMEMS HERO device—a next-generation pulmonary artery (PA) pressure reader—to support the care of people living with heart failure. The reader contains new design features to help empower heart failure patients and their clinicians with the daily insights they need to detect and combat heart failure progression, the company says i…

Abbott secures FDA approval for CardioMEMS HERO device

Abbott has secured the US FDA approval for its next generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring.The post Abbott secures FDA approval for CardioMEMS HERO device  appeared first on Medical Device Network.